FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer

FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer

10 Takeover Targets to Watch This Fall

10 Takeover Targets to Watch This Fall

FDA Action Alert: Nabriva, Seattle Genetics, Sarepta and Nektar

FDA Action Alert: Nabriva, Seattle Genetics, Sarepta and Nektar

Asco 2019 event analyser – low-key meeting belies some huge stock moves

Asco 2019 event analyser – low-key meeting belies some huge stock moves

All the ASCO skinny: Lynparza’s pancreatic win, Amgen’s KRAS spotlight, Merck’s history-busting and more

All the ASCO skinny: Lynparza's pancreatic win, Amgen's KRAS spotlight, Merck's history-busting and more

The winners and losers from JPM 2019

The winners and losers from JPM 2019